Cellavision Q1’22: Slighty more upbeat
Research Note
2022-05-10
08:34
Redeyes view on the Q1 report. With a report slightly above our estimates, we only make minor adjustments to our forecasts for the current year. We leave our Base case at SEK 340 unchanged.
MH
Mats Hyttinge
Disclosures and disclaimers